Episode Details

Back to Episodes

Reden wir über Brustkrebs! Experten diskutieren aktuelle CDK4/6-Daten und ihre klinische Anwendung

Episode 231 Published 1 year, 6 months ago

Description

Zum Weiterlesen:

Loibl S et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024, 35(2):159-182

https://www.annalsofoncology.org/article/S0923-7534(23)05104-9/fulltext

Kalinsky K et al. Abemaciclib plus fulvestrant vs fulvestrant alone for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy: Primary outcome of the phase 3 postMONARCH trial. J Clin Oncology 2024,42(17suppl): LBA1001

https://ascopubs.org/doi/10.1200/JCO.2024.42.17_suppl.LBA1001

FKI Verzenios (Abemaciclib)

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.